IP Library › Granted Patent US 8,372,819
Granted Patent B2
US 8,372,819 · App. 13/078,813 · Granted Feb 12, 2013

Methods and compositions for targeting skip

Inventors: Katherine Jones (Solana Beach, CA); Lirong Zhang (San Diego, CA); Vanessa Bres (San Diego, CA); Yupeng Chen (San Diego, CA)
Assignee: Salk Institute for Biological Studies
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,819
App. No.
13/078,813
Granted
Feb 12, 2013
Kind
B2
Abstract

Provided herein are methods and compositions for modulating apoptosis by targeting SKIP (Ski-interacting protein) activity. Methods of increasing DNA damage-induced cell death in cancer cells, and reducing DNA damage-induced cell death in normal cells are provided.

Claims (12)

1. A method of treating colon cancer in an individual comprising: administering to the individual an effective amount of an anti-SKIP siRNA, thereby treating colon cancer in the individual.

2. The method of claim 1 , further comprising treating the individual with a DNA damaging agent.

3. The method of claim 2 , wherein treatment with the DNA damaging agent is before or concurrent with said administering.

4. The method of claim 2 , wherein the DNA damaging agent is a chemotherapeutic agent or radiotherapy.

5. The method of claim 1 , wherein the inhibitor of SKIP is flavopiridol.

6. A method of selectively inducing apoptosis in a colon cell comprising: contacting the colon cell with an anti-SKIP siRNA, thereby selectively inducing apoptosis in a colon cell.

7. The method of claim 6 , further comprising treating the colon cell with a DNA damaging agent.

8. The method of claim 7 , wherein treatment with the DNA damaging agent before or concurrently with the contacting.

9. The method of claim 6 , wherein the colon cell forms part of a colon tumor.

10. The method of claim 6 , wherein the inhibitor of SKIP is flavopiridol.

11. The method of claim 6 , wherein the colon cell is in an individual.

12. The method of claim 11 , wherein the individual has colon cancer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2011
From: JONES, KATHERINE; ZHANG, LIRONG; BRES, VANESSA; CHEN, YUPENG
To: SALK INSTITUTE FOR BIOLOGICAL STUDIES
Reel/Frame 026608/0169 →
Continuity (2)
Provisional Application 61322890 · Apr 11, 2010
Related Publication 20110269819A1 · Nov 3, 2011